Insamo

About:

Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides at an unprecedented scale.

Top Investors: MRL Ventures Fund, Playground Global, Sahsen Ventures, Civilization Ventures, Axial VC

Description:

Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which lies in its automated process of designing, synthesizing, and testing at an unprecedented scale.

Total Funding Amount:

$12M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2022-01-01

Founders:

Timothy Craven, Toby Passioura

Number of Employees:

11-50

Last Funding Date:

2024-02-21

IPO Status:

Private

Industries: